Fresenius Medical Care AG & Co. KGaA

Total Valuation

Fresenius Medical Care AG & Co. KGaA carries a market capitalization of 11.95B, placing it among publicly traded companies globally. Its enterprise value stands at 5.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Fresenius Medical Care AG & Co. KGaA currently has 270.09M shares outstanding.

Valuation Ratios

Fresenius Medical Care AG & Co. KGaA trades at a trailing price-to-earnings ratio of 15.43.

Enterprise Valuation

On an enterprise value basis, Fresenius Medical Care AG & Co. KGaA trades at an EV/EBITDA multiple of 2.04 and an EV/FCF ratio of 1.78. The EV/Sales ratio of 0.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.75 provides insight into valuation relative to core operating earnings.

Financial Position

Fresenius Medical Care AG & Co. KGaA maintains a current ratio of 4.90, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 309.55, indicating elevated leverage, while an interest coverage ratio of 9.18 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Fresenius Medical Care AG & Co. KGaA posts a return on equity of 10.84 and a return on invested capital of 8.94.

Taxes

Over the trailing twelve months, Fresenius Medical Care AG & Co. KGaA has paid 224.42M in income taxes, reflecting an effective tax rate of 20.06.

Stock Price Statistics

Fresenius Medical Care AG & Co. KGaA's stock has declined approximately -16.82243% over the past 52 weeks. The 50-day moving average sits at 23.36, while the 200-day moving average is 23.03.

Income Statement

Over the trailing twelve months, Fresenius Medical Care AG & Co. KGaA generated 14.57B in revenue and converted that into 719.40M in net income, yielding earnings per share of 1.59. EBITDA reached 2.62B, while operating income came in at 1.43B.

Cash Flow

Fresenius Medical Care AG & Co. KGaA produced 1.97B in operating cash flow over the past twelve months. After subtracting -805.29M in capital expenditures, free cash flow totaled 1.16B - equivalent to 2.08 per share.

Margins

Fresenius Medical Care AG & Co. KGaA operates with a gross margin of 26.16, reflecting its pricing power and cost economics. The operating margin of 9.79 and net profit margin of 4.94 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Fresenius Medical Care AG & Co. KGaA's most recent stock split took place on December 4, 2012 with a 1:2 split ratio.

Scores

Fresenius Medical Care AG & Co. KGaA posts an Altman Z-Score of 11.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.